Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Loading Pathway...

Adenylate cyclase type 10 Myosin light chain kinase, smooth muscle PKA complex PKA complex Protein kinase C Muscarinic acetylcholine receptor M2 Myosin LC-P Myosin light chain 3 Inositol 1,4,5- trisphosphate receptor type 1 Voltage- dependent L-type calcium channel subunit beta-1 Voltage- dependent L-type calcium channel subunit alpha-1C Myosin light chain phosphatase Calmodulin Intermediate conductance calcium- activated potassium channel protein 4 Phospholipase C ATP-binding cassette sub-family C member 8 ATP-sensitive inward rectifier potassium channel 8 ATP-sensitive inward rectifier potassium channel 11 ATP-binding cassette sub-family C member 9 Calmodulin Voltage- dependent calcium channel subunit alpha-2/delta-1 Anisotropine Methylbromide Ca+ Ca+ K+ K+ Ca+ K+ K+ Anisotropine Methylbromide ATP cAMP Inositol 1,4,5-trisphosphate Phosphatidylinositol 4,5-bisphosphate Diacylglycerol Pi Pi Pi Pi Calcium Ca+ Muscle Contraction Muscle Relaxation G Protien Signalling Cascade Magnesium Calcium Manganese Sarcoplasmic Reticulum Cytosol GI Tract Smooth Muscle Cell Activated PKA can phosphorylate calcium activated potassium channels causing potassium efflux and promoting hyperpolarization. Activated PKA phosphorylates the IP3 receptor to reduce its affinity for IP3. Activated PKA phosphorylates phospholipase C. There is an overall decrease in calcium levels in the cytosol. Decreased calcium is unable to bind readily to calmodulin. The inhibition of myosin light chain kinase prevents the synthesis of Myosin LC-P which leads to a high concentration of myosin light chain and muscle relaxation. Myosin unbinds from actin causing the sarcomere filaments to slide resulting in muscle relaxation. Activates ATP-sensitive potassium channels via cAMP mediated phosphorylation. Actin Filament Myosin Filament Since the receptor isn't activated, adenylyl cyclase is no longer inhibited allowing for cAMP production M2 receptors activate Gi protein signalling which inhibits adenylyl cyclase Anisotropine methylbromide antagonizes the M2 receptor in the GI tract, while also antagonizing both M1 and M3 receptors Anisotropine methylbromide is administered as an oral tablet
ADCY10 MYLK PRKAR1A PRKAR2A PRKCA CHRM2 MYL3 MYL3 ITPR1 CACNB1 CACNA1C PPP1CB CALM1 KCNN4 PLCB1 ABCC8 KCNJ8 KCNJ11 Unknown CALM1 CACNA2D1 Anisotropine Methylbromide Calcium Calcium Potassium Potassium Calcium Potassium Potassium Anisotropine Methylbromide Adenosine triphosphate cAMP Inositol 1,4,5- trisphosphate Phosphatidylinositol 4,5- bisphosphate Diacylglycerol Phosphate Phosphate Phosphate Phosphate Calcium Muscle Contraction Muscle Relaxation G Protien Signalling Cascade
ADCY10 MYLK PRKAR1A PRKAR2A PRKCA CHRM2 MYL3 MYL3 ITPR1 CACNB1 CACNA1C PPP1CB CALM1 KCNN4 PLCB1 ABCC8 KCNJ8 KCNJ11 CALM1 CACNA2D1 AM Ca+ Ca+ K+ K+ Ca+ K+ K+ AM ATP cAMP Inotp P45P Diacylg Pi Pi Pi Pi Ca2+ Ca+ Mus Con Mus Rel G P S C Mg2+ Ca2+ Mn2+ Sarcoplasmic Reticulum Cytosol GI Tract Smooth Muscle Cell Activated PKA can phosphorylate calcium activated potassium channels causing potassium efflux and promoting hyperpolarization. Activated PKA phosphorylates the IP3 receptor to reduce its affinity for IP3. Activated PKA phosphorylates phospholipase C. There is an overall decrease in calcium levels in the cytosol. Decreased calcium is unable to bind readily to calmodulin. The inhibition of myosin light chain kinase prevents the synthesis of Myosin LC-P which leads to a high concentration of myosin light chain and muscle relaxation. Myosin unbinds from actin causing the sarcomere filaments to slide resulting in muscle relaxation. Activates ATP-sensitive potassium channels via cAMP mediated phosphorylation. Actin Filament Myosin Filament Since the receptor isn't activated, adenylyl cyclase is no longer inhibited allowing for cAMP production M2 receptors activate Gi protein signalling which inhibits adenylyl cyclase Anisotropine methylbromide antagonizes the M2 receptor in the GI tract, while also antagonizing both M1 and M3 receptors Anisotropine methylbromide is administered as an oral tablet
ADCY10 MYLK PRKAR1A PRKAR2A PRKCA CHRM2 MYL3 MYL3 ITPR1 CACNB1 CACNA1C PPP1CB CALM1 KCNN4 PLCB1 ABCC8 KCNJ8 KCNJ11 CALM1 CACNA2D1 AM Ca2+ Ca2+ K+ K+ Ca2+ K+ K+ AM ATP cAMP Inotp P45P Diacylg Pi Pi Pi Pi Ca2+ Mus Con Mus Rel G P S C